Computational Biology and Statistical Modeling Core (CORE B) (University of California, Berkeley) SUMMARY The Computational Biology and Statistical Modeling Core (Core B) will provide essential services to individual Projects and the Program Project (P01) as a whole by providing statistical support at each stage of research. Critically, Core B will enable the Projects to address key themes of the P01 by applying unifying computational biology, statistical, and machine learning approaches to study natural and vaccine-induced dengue humoral and cellular immunity.
In Aim 1, Core B will conduct epidemiological analyses of the natural dengue virus (DENV) infection and dengue vaccine cohorts to inform the immunological studies proposed by Projects 1, 2, and 3. For the Nicaragua Pediatric Dengue Cohort Study, we will work closely with Core C to investigate dengue incidence before and after the introduction of Zika as well as how changing DENV transmission intensity affects dengue disease severity. For the Cebu Dengvaxia cohort, we will estimate DENV infection and dengue disease incidence stratified by baseline DENV serostatus and vaccination history to support the immune correlates studies proposed by Project 2. We will also compare these two pediatric cohorts to understand how geography, DENV transmission intensity, ZIKV infection history, and serotype prevalence affect dengue disease. Phylogenetic and phylodynamic analyses will be conducted for all DENV isolates from both cohorts.
In Aim 2, we will support each Project individually and conduct cross-Project analyses to identify immune markers that correlate with protection against symptomatic dengue and pathogenesis of severe dengue disease.
This aim encompasses immune correlates of natural and vaccine-induced DENV immunity. We will work with each Project to design case-control studies to test how DENV-specific serum antibody, B cell, and T cell characteristics predict distinct clinical outcomes. Core B will analyze the multi-dimensional datasets produced by the Projects to classify clinical outcomes using straightforward machine learning methods such as generalized linear models, flexible approaches such as random forests, and methods that are robust to outliers such as support vector machines, all with regularization to reduce model complexity.
In Aim 3, we will support the Projects in studying children who have experienced natural primary and secondary DENV infections to identify immune markers that predict maintenance anti-DENV immunity. We will use regression models to determine how antibody and helper T cell characteristics measured soon after infection predict both the magnitude and the durability of cross-reactive and type-specific antibody responses. We will then incorporate the predictive immune markers into linear and more flexible mixed-effects regression models to fit antibody dynamics following primary and secondary DENV infection. Parallel analyses will be conducted for baseline seronegative and seropositive vaccine recipients, enabling direct comparison of the determinants of immune longevity following natural DENV infection and vaccination. We also compare the systems serology measures performed on post-primary, pre-secondary, and post-secondary natural DENV infection samples in the same individuals to test for changes in antibody antigen recognition and Fc effector characteristics. Collectively, these three Aims are critical to the research proposed in the Projects and will work toward the overarching P01 goal to identify predictive and mechanistic anti-DENV immune characteristics that provide long-term protection against dengue disease.!

Public Health Relevance

CORE B Dengue is a viral disease with a high global burden, yet currently, the only licensed dengue vaccine cannot be widely administered because it can increase severity of dengue disease. Comprehensive characterization of the protective and pathogenic features of immunity in the context of natural dengue and dengue vaccines is urgently needed to improve control efforts. Core B will support this Program Project, which directly addresses these themes, by: epidemiological and phylogenetic analyses of natural infection and vaccine cohorts; experimental designs, sampling strategies, and analysis plans for within and cross-Project studies; and application of statistical and machine learning approaches to interpret high-dimensional adaptive immune characteristics and to identify immune correlates of protection, pathogenesis, and dynamics of anti-dengue virus immunity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI106695-06
Application #
9856090
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2015-07-29
Project End
2025-07-31
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Berkeley
Department
Type
DUNS #
124726725
City
Berkeley
State
CA
Country
United States
Zip Code
94710
Scott, Jason M; Lebratti, Tania J; Richner, Justin M et al. (2018) Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice. J Virol :
Andrade, Paulina; Coloma, Josefina; Harris, Eva (2018) ELISPOT-Based ""Multi-Color FluoroSpot"" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections. Methods Mol Biol 1808:151-163
Zambrana, José Victor; Bustos Carrillo, Fausto; Burger-Calderon, Raquel et al. (2018) Seroprevalence, risk factor, and spatial analyses of Zika virus infection after the 2016 epidemic in Managua, Nicaragua. Proc Natl Acad Sci U S A 115:9294-9299
Regla-Nava, Jose Angel; Elong Ngono, Annie; Viramontes, Karla M et al. (2018) Cross-reactive Dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy. Nat Commun 9:3042
Montoya, Magelda; Collins, Matthew; Dejnirattisai, Wanwisa et al. (2018) Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas. J Infect Dis 218:536-545
Fowler, Angela M; Tang, William W; Young, Matthew P et al. (2018) Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice. Cell Host Microbe 24:743-750.e5
Burger-Calderon, Raquel; Gonzalez, Karla; Ojeda, Sergio et al. (2018) Zika virus infection in Nicaraguan households. PLoS Negl Trop Dis 12:e0006518
Tsai, Wen-Yang; Youn, Han Ha; Tyson, Jasmine et al. (2018) Use of Urea Wash ELISA to Distinguish Zika and Dengue Virus Infections. Emerg Infect Dis 24:1355-1359
Gallichotte, Emily N; Baric, Thomas J; Yount Jr, Boyd L et al. (2018) Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes. PLoS Pathog 14:e1006934
Katzelnick, Leah C; Harris, Eva (2018) The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection. Curr Opin Virol 29:51-61

Showing the most recent 10 out of 54 publications